Skip to main content
Bora logo

Bora — Investor Relations & Filings

Ticker · 6472 ISIN · TW0006472004 LEI · 254900MK7O5C2UX1SY03 TW Manufacturing
Open in API
Filings indexed 63 across all filing types
Latest filing 2026-04-20 Proxy Solicitation & In…
Country TW Taiwan
Listing TW 6472

About Bora

https://bora-corp.com/

Bora Pharmaceuticals Co., Ltd. is a global pharmaceutical service provider that operates through a "dual-engine" business model, integrating comprehensive Contract Development and Manufacturing Organization (CDMO) services with the development and commercialization of specialty pharmaceuticals. The company provides end-to-end solutions ranging from formulation development and clinical trial materials to large-scale commercial manufacturing. Its technical capabilities encompass a diverse array of dosage forms, including oral solids, liquids, and semi-solids. With a manufacturing footprint spanning multiple continents, the company serves global markets by leveraging advanced production technologies and rigorous quality management systems. Bora Pharmaceuticals focuses on strategic growth through acquisitions and partnerships, aiming to enhance manufacturing efficiency and accelerate the delivery of complex therapeutic treatments to patients worldwide.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議召開115年股東常會相關事宜 (更新召集事由三)
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal announcement by the board of directors calling the 115th shareholders’ meeting, listing date, location, agenda items, reasons for convening, and proxy‐related details. It is not the AGM materials themselves (AGM‐R) nor a post‐meeting voting results notice (DVA). It serves as information sent to shareholders to inform and solicit votes for the meeting, matching the Proxy Solicitation & Information Statement category.
2026-04-20 Chinese
公告本公司國內第五次無擔保轉換公司債收足應募價款
Capital/Financing Update Classification · 85% confidence The document is an announcement by a listed company (保瑞藥業) that its domestic fifth unsecured convertible corporate bond subscription money has been fully collected and deposited. This relates to the company’s fundraising and issuance of convertible bonds (a financing activity). Therefore, it falls under Capital/Financing Update.
2026-04-13 Chinese
115年04月僑外投資持股
Regulatory Filings Classification · 71% confidence The document is a statutory disclosure of Taiwan-listed company shareholdings by overseas Chinese and Mainland China investors as of a specified date. It is not announcing a shareholder meeting result, not an earnings report, not a threshold crossing by a specific major holder, nor a capital change or AGM material. It is a general regulatory report required by the exchange (公開資訊觀測站) providing shareholding statistics. This falls under the catch-all “Regulatory Filings” category (RNS).
2026-04-13 Chinese
115年3月背書保證與資金貸與
Regulatory Filings Classification · 30% confidence The document is extremely short (25 characters) and contains no substantive content or reference to any specific report or announcement. It simply indicates that no data is available. It does not match any specific filing category. Therefore, it falls into the fallback category for miscellaneous regulatory announcements.
2026-04-09 Chinese
115年3月營業收入
Regulatory Filings Classification · 87% confidence The document is a brief disclosure from Taiwan’s MOPS system showing monthly and year-to-date net operating revenue figures for a listed company. It is under 5,000 characters and merely presents summarized revenue data without being a full interim or annual report. It therefore qualifies as a general regulatory announcement rather than a standalone report like an IR or 10-K. The appropriate category is Regulatory Filings (RNS).
2026-04-09 Chinese
115年03月內部人持股異動(事後)
Director's Dealing Classification · 87% confidence The document is a disclosure of shareholdings and changes in holdings by company insiders (directors, chairman, management and related parties). It is not an earnings or annual report, but an insider share transaction/holdings report, which corresponds to Director’s Dealing.
2026-04-08 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.